Skip to content

filings.toolsA Dark Vector Cognition product

Item 6. Selected Financial Data

3K characters. Original on sec.gov · Markdown

Item 6. Selected Financial Data

| --- | --- |

The financial information for each of the past five years ended December 31 is set forth below (in millions, except per share amounts):

		2018				2017				2016				2015 (1)(2)				2014 (1)
STATEMENT OF EARNINGS DATA
Net sales		$	7,932.9			$	7,803.3			$	7,668.4			$	5,997.8			$	4,673.3
Net (loss) earnings of Zimmer Biomet Holdings, Inc.			(379.2	)			1,813.8				305.9				147.0				720.3
(Loss) earnings per common share
Basic		$	(1.86	)		$	8.98			$	1.53			$	0.78			$	4.26
Diluted			(1.86	)			8.90				1.51				0.77				4.20
Dividends declared per share of common stock		$	-			$	-			$	-			$	0.88			$	0.88
Average common shares outstanding
Basic			203.5				201.9				200.0				187.4				169.0
Diluted			203.5				203.7				202.4				189.8				171.7
BALANCE SHEET DATA
Total assets		$	24,126.8			$	26,014.0			$	26,684.4			$	27,160.6			$	9,658.0
Long-term debt			8,413.7				8,917.5				10,665.8				11,497.4				1,425.5
Other long-term obligations			2,015.7				2,291.3				3,967.2				4,155.9				656.8
Stockholders' equity			11,276.1				11,735.5				9,669.9				9,889.4				6,551.7

(1)	Effective January 1, 2018 we adopted Accounting Standards Update 2014-09 – Revenue from Contracts with Customers (Topic 606). We adopted this new standard using the retrospective method, which resulted in us restating the 2017 and 2016 periods. The 2015 and 2014 periods have not been restated. See Note 2 to our consolidated financial statements for additional information.

(2)	Includes the results of Biomet starting on June 24, 2015 and Biomet balance sheet data as of December 31, 2015.

Previous: Item 5. Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities · Next: Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations